New Inflammatory Disease Treatment (2022), which reduces pre-inflammatory reactions and increases M2 macrophages according to the repolarization of macrophages, has fewer side effects and shows excellent anti-inflammatory effects at low doses compared to conventional steroid treatments

Novel therapeutic agent for inflammatory disease

A novel therapeutic agent for treating inflammatory diseases which reduces the pro-inflammatory response and increases M2 macrophages according to the repolariza- tion of macrophages, thereby exhibiting fewer side effects and excellent Anti-inflammatory effects even at low doses compared to conve- ntional steroid anti-inflammatory agent (2021)

NIR-responsive stem cell-derived inflammation attenuating complex and use thereof

It is about an inflammation-suppressing complex using infrared-responsive thermal stem cells, and more specifically, to an inflammation-inhibiting complex using infrared-responsive thermal stem cells and its uses (2023)

Method of strengthening the ability of stem cells to move to the inflammatory area

It is about how to strengthen the performance of new stem cells, and more specifically, how to strengthen the mobility of stem cells to the inflammatory site, including the step of culturing stem cells in the culture of inflammation-related cells. (2021)

Method of enhancing mobility of stem cells to inflammatory lesion

A novel method for enhancing the performan- ce of stem cells, and more particularly, a met- hod for enhancing the ability of stem cells to migrate to an inflammatory site, comprising culturing the stem cells in a culture medium of inflammation-related cells, and a therapeutic use of the stem cells having enhanced ability to migrate to an inflammatory site for treating inflammatory diseases or autoimmune diseases (2022)

Method of enhancing the mobility of stem cells into cancer cells

It is about how to strengthen the mobility of stem cells into cancer cells in culture, including stem cell education steps that process cell culture and optionally anion channel activator of cancer cells obtained from cancer patients (2021)

Method for enhancing migration of stem cells into cancer cells

A method for improving the migration ability of stem cells into cancer cells comprising educa- ting the stem cells by treating the stem cells with an in vitro cell culture medium of cancer cells obtained from a cancer patient to be tre- ated and optionally an anionic channel activator (2020)

Stem cell-nanodrug carrier complex and its application

Stem cell-nano anticancer drug complex (2019) loaded with carbon nanotube (CNT) and gold (Au) nanoparticle-based anticancer drugs on a stem cell surface that overcomes the target limitations of existing stem cell side effects and nano anticancer drugs and has excellent anticancer effect

Stem cell-nano drug delivery system complex, use thereof and method for prepar- ing the same

A stem cell-nano anticancer drug complex in which an anticancer drug based on carbon nanotubes (CNT) and gold (Au) nano particles is loaded on the surface of stem cells, which can overcome side effects of conventional stem cells and targeting limitations of nano anticancer drugs and whose anticancer effect is very excellent, the use thereof, and method for preparing the same (2018)

Method of manufacturing stem cell-nanocomposite

A method of manufacturing a stem cell-nano anticancer drug complex in which carbon nanotubes (CNT) and gold (Au) nanoparticles-based anticancer drugs are loaded on a stem cell surface that overcomes existing stem cell side effects and target limitations of nano anticancer drugs (2019) and has excellent anticancer effects

A method of manufacturing an ectosome-PLGA complex with enhanced target capability for lesions

It is about the manufacturing method of a new ectosome-biodegradable polymer nanoparticle complex, and more particularly, a manufacturing method of an ectosome-biodegradable polymer nanoparticle complex with enhanced targeting on tumors and inflammatory sites (2022)

Ectosome-Biodegradable Polymer Nanoparticle Complex with Enhanced Targeting Capability for Disease and Its Use

It is about a new ectosome-biodegradable polymer nanoparticle complex, and more particularly, the ectosome-biodegradable polymer nanoparticle complex (2022) with enhanced targeting on tumors and inflammatory sites